迈克生物：关于对全资子公司增资完成工商变更登记并换发营业执照的公告

Core Viewpoint - The company announced a capital increase through debt-to-equity conversion for its wholly-owned subsidiaries, aiming to strengthen their financial positions and support future growth [2] Group 1: Capital Increase Details - The company increased the capital of its wholly-owned subsidiary, Mike Medical Electronics Co., Ltd., by RMB 60 million, raising its registered capital from RMB 10 million to RMB 70 million [2] - The capital of another wholly-owned subsidiary, Sichuan Mike Medical Technology Co., Ltd., was increased by RMB 100 million, raising its registered capital from RMB 15 million to RMB 115 million [2] - Both subsidiaries have completed the necessary business registration changes and obtained new business licenses from the market supervision administration [2]